Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04553133
Title PF-07104091 as a Single Agent and in Combination Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pfizer
Indications

triple-receptor negative breast cancer

lung small cell carcinoma

Her2-receptor negative breast cancer

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer

lung non-small cell carcinoma

Therapies

PF-07104091

Letrozole + Palbociclib + PF-07104091

Palbociclib + PF-07104091

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.